doi:10.1016/S0959-8049(98)80358-4Peto RClarke MCollins RDavies CGray REuropean Journal of CancerPeto R., Clarke M., Collins R. et al. Facts and figures from the meta-analyses in breast cancer. Eur J Cancer 1998; 34.
Breast cancer- Facts and Figures. This chapter first outlines the epidemiology of breast cancer around the world, looking at national and international incidence and prevalence, along with survival figures for symptomatic and screen detected breast cancers. A comparison is also made between different so...
Breast cancer (BC) is a complex disease with profound genomic aberrations. However, the underlying molecular disparity influenced by age and ethnicity remains elusive. In this study, we aimed to investigate the molecular properties of 843 primary and met
eFigure. US Preventive Services Task Force (USPSTF) Grades and Levels of Evidence 1. Surveillance Epidemiology and End Results Program. Cancer Stat Facts: female breast cancer. National Cancer Institute. Accessed March 5, 2024. https://seer.cancer.gov/statfacts/html/breast.html 2. Surveillance ...
Breast cancer is the most common noncutaneous malignancy and the second most lethal form of cancer among women in the United States. It currently affects more than one in ten women worldwide. The chance for a female to be diagnosed with breast cancer during her lifetime has significantly incre...
Breast cancer is the most common type of cancer among women worldwide. The standard histopathology of breast tissue, the primary means of disease diagnosis, involves manual microscopic examination of stained tissue by a pathologist. Because this method relies on qualitative information, it can result...
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402-2416. doi:10.1001/jama.2017.7112ArticlePubMedGoogle ScholarCrossref 9. American Cancer Society (ACS). Breast Cancer Facts & Figures 2017-2018. ACS website. https://www...
Cancer cells show characteristic effects on cellular turnover and DNA/RNA modifications leading to elevated levels of excreted modified nucleosides. We investigated the molecular signature of different subtypes of breast cancer cell lines and the breast epithelial cell line MCF-10A. Prepurification of ce...
Young women’s breast cancer (YWBC) has poor prognosis and known interactions with parity. Women diagnosed within 5–10 years of childbirth, defined as postpartum breast cancer (PPBC), have poorer prognosis compared to age, stage, and biologic subtype-matched nulliparous patients. Genomic differenc...
Many factors, including reproductive hormones, have been linked to a woman’s risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs) and BC risk. Physiological variations in t